Chison Medical Technologies Co., Ltd. (688358.SS)
CNY 28.78
(0.14%)
CNY 28.78
(0.14%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 10.33 Million CNY | 69.22% |
| 2022 | 6.1 Million CNY | 346.79% |
| 2021 | 1.36 Million CNY | -22.34% |
| 2020 | 1.76 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 8.32 Million CNY | -13.3% |
| 2024 Q3 | 5.76 Million CNY | -59.64% |
| 2024 Q1 | 9.6 Million CNY | -7.1% |
| 2023 Q4 | 10.33 Million CNY | 51.12% |
| 2023 FY | 10.33 Million CNY | 69.22% |
| 2023 Q3 | 6.84 Million CNY | -1.54% |
| 2023 Q2 | 6.94 Million CNY | 12.9% |
| 2023 Q1 | 6.15 Million CNY | 0.73% |
| 2022 Q4 | 6.1 Million CNY | 629.48% |
| 2022 Q3 | 837.55 Thousand CNY | -14.87% |
| 2022 Q2 | 983.91 Thousand CNY | -19.64% |
| 2022 Q1 | 1.22 Million CNY | -10.46% |
| 2022 FY | 6.1 Million CNY | 346.79% |
| 2021 FY | 1.36 Million CNY | -22.34% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 Q4 | 1.36 Million CNY | 20.29% |
| 2021 Q3 | 1.13 Million CNY | -8.23% |
| 2021 Q2 | 1.23 Million CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 1.76 Million CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Shenzhen Lifotronic Technology Co., Ltd. | 243.47 Million CNY | 95.754% |